Thus, the amyloid accumulation in the NASH induced group is enhanced by limiting Aβ degradation via decreasing the insulin sensitivity which in turn competes for the IDE sites and impairs aggregated amyloids clearance. Here, INS is linked to metabolic dysfunction-associated steatohepatitis.